Why Assessa?

Dementia is a devastating condition not only for the person affected but also for their family and friends. With an estimated 47 million people living with dementia worldwide, and with a projected increase to 78m in 2030 and 132m in 2050, it is crucial to find a way to diagnose and manage this debilitating condition. There are over 10m new cases of dementia every year and the global cost of dementia in 2015 is estimated at $818bn. Early and efficient diagnosis of dementia has been identified as a high priority by policy makers and clinicians.

Alzheimer's disease (AD) is the most common cause of dementia, accounting for 60-80% of cases, followed by an estimated 10% of cases exclusively attributed to vascular dementia and then less common causes like frontotemporal dementia or dementia with Lewy bodies. The number of cases with mixed pathology is less clear but crucial to providing effective disease management. 

Differentiating between sub-types of dementia is important to enable the timely treatment of patients with effective symptomatic therapies as well as to reduce costs of care and mis-diagnosis. A timely, confident and accurate diagnosis followed by appropriate drug and non-drug interventions is key to controlling costs and improving the quality of life for both people with dementia and their carers. Carefully linking a high quality and differentiated diagnosis to care-planning and on-going support can smooth the transition into other care settings.

See more